Formulation and characterization of carvedilol leciplex for glaucoma treatment: in-vitro, ex-vivo and in-vivo study

DH Hassan, R Abdelmonem, MM Abdellatif - Pharmaceutics, 2018 - mdpi.com
This study evaluated the efficacy of cationic nanoparticle (leciplex) to deliver carvedilol to
ocular surface for glaucoma treatment as recent studies pointed out the effect of topical …

Natural bioadhesive biodegradable nanoparticle-based topical ophthalmic formulations for management of glaucoma

MM Ibrahim, AEH Abd-Elgawad… - … vision science & …, 2015 - tvst.arvojournals.org
Purpose:: We prepared and characterized topical ophthalmic formulations containing
brimonidine-loaded bioadhesive cationic chitosan or anionic alginate nanoparticles (NPs) …

Betaxolol hydrochloride loaded chitosan nanoparticles for ocular delivery and their anti-glaucoma efficacy

K Jain, R Suresh Kumar, S Sood… - Current drug …, 2013 - ingentaconnect.com
Many effective anti-glaucoma drugs available for the treatment of ocular hypertension and
open angle glaucoma are associated with rapid and extensive precorneal loss caused by …

Chitosan nanoparticles amplify the ocular hypotensive effect of cateolol in rabbits

J Ali, A Bhatnagar, N Kumar, A Ali - International journal of biological …, 2014 - Elsevier
Purpose To assess the potential of chitosan (CS) nanoparticles for ocular drug delivery by
investigating their intraocular retention by γ-scintigraphy and intraocular pressure reduction …

Extended levobunolol release from Eudragit nanoparticle-laden contact lenses for glaucoma therapy

N Kumar, R Aggarwal, MK Chauhan - Future Journal of Pharmaceutical …, 2020 - Springer
Background Majorly, the reason for the permanent loss of vision is glaucoma. But the
currently available common treatment methodologies such as eye drops have various …

Optimization and evaluation of encapsulated brimonidine tartrate-loaded nanoparticles incorporation in situ gel for efficient intraocular pressure reduction

PK Sharma, MK Chauhan - Journal of Sol-Gel Science and Technology, 2020 - Springer
Brimonidine tartrate (BRT) is a water-soluble anti-glaucoma drug that is available in
ophthalmic solution (Alphagan Z®). Various ocular barriers prevent permeation and …

Montmorillonite/chitosan nanoparticles as a novel controlled-release topical ophthalmic delivery system for the treatment of glaucoma

J Li, S Tian, Q Tao, Y Zhao, R Gui, F Yang… - International journal …, 2018 - Taylor & Francis
Background To date, the rapid clearance from ocular surface has been a huge obstacle for
using eye drops to treat glaucoma, since it has led to the short preocular residence time and …

Development of Carvedilol Nanoformulation-Loaded Poloxamer-Based In Situ Gel for the Management of Glaucoma

BK Almutairy, ES Khafagy, AS Abu Lila - Gels, 2023 - mdpi.com
The objective of the current study was to fabricate a thermosensitive in situ gelling system for
the ocular delivery of carvedilol-loaded spanlastics (CRV-SPLs). In situ gel formulations …

Optimization and characterization of brimonidine tartrate nanoparticles-loaded in situ gel for the treatment of glaucoma

PK Sharma, MK Chauhan - Current Eye Research, 2021 - Taylor & Francis
Purposes: The present study aimed to develop brimonidine tartrate loaded poly (lactic-co-
glycolic acid) acid vitamin E-tocopheryl polyethylene glycol 1000 succinate (BRT-PLGA …

Novel topical ophthalmic formulations for management of glaucoma

MM Ibrahim, AEH Abd-Elgawad, OA Soliman… - Pharmaceutical …, 2013 - Springer
Purpose Preparation of topical ophthalmic formulations containing brimonidine-loaded
nanoparticles prepared from various biodegradable polymers—PCL, PLA and PLGA—for …